REMEGEN

09995

----

Current ValuationThe current P/E ratio is 5.92, within the reasonable range, cheaper than 53.26% of the time in the past 1 years, and the industry ranks 5/78, the industry Median -5.11.

5.92xP/E

Stock priceHK$70.30Earnings per shareHK$11.87

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

0155310465620

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x30x60x90x120x150x

P/E ratio
Name/Symbol
09995HKREMEGEN	5.92x	489.28%	HK$39.68B
01530HK3SBIO	3.89x	71.56%	HK$37.04B
02142HKHBM HOLDINGS-B	14.32x	17.57%	HK$9.49B
01167HKJACOBIO-B	7.04x	--	HK$4.17B
02509HKQYUNS-B	5.95x	23.95%	HK$3.74B
06998HKEDDING GENOR	13.30x	--	HK$3.35B
02197HKCLOVER BIO-B	2.21x	--	HK$2.17B
02566HKJIUYUAN GENE	8.39x	--	HK$1.35B
01061HKESSEX BIO-TECH	4.43x	1.60%	HK$1.17B
00690HKUNI-BIO GROUP	8.61x	--	HK$417.99M
08158HKCRMI	3.42x	--	HK$94.32M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.